Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Archives of Internal Medicine

• Publication date

  2006-04-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHINTE.166.8.837PMID 16636208
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta‐Analysis

  2008cited by this paper
• Health‐related consequences of overactive bladder: an economic perspective

  2005cited by this paper
• Lower urinary tract symptoms in the danish population: a population-based study of symptom prevalence, health-care seeking behavior and prevalence of treatment in elderly males and females.

  2005cited by this paper
• Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin: systematic review and meta-analysis of randomized controlled trials.

  2005cited by this paper
• Opioid switching to improve pain relief and drug tolerability.

  2004cited by this paper
• Palliative care research: issues and opportunities.

  2004cited by this paper
• Opioids in chronic non‐cancer pain: systematic review of efficacy and safety

  2004cited by this paper
• Health-related quality of life associated with chronic conditions in eight countries: Results from the International Quality of Life Assessment (IQOLA) Project

  2004cited by this paper
• Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

  2003cited by this paper
• Minimizing predictability while retaining balance through the use of less restrictive randomization procedures

  2003cited by this paper
• Comparison of lower urinary tract symptom severity and associated bother between community-dwelling black and white men: the Olmsted County Study of Urinary Symptoms and Health Status and the Flint Men's Health Study.

  2003cited by this paper
• Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review.

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Clinically important changes in acute pain outcome measures: a validation study.

  2003cited by this paper
• Lower urinary tract symptoms: social influence is more important than symptoms in seeking medical care

  2002cited by this paper
• Meta‐analysis combining parallel and cross‐over clinical trials. I: Continuous outcomes

  2002influential reference
• Systematic reviews in health care: Assessing the quality of controlled clinical trials.

  2001cited by this paper
• Morphine and alternative opioids in cancer pain: the EAPC recommendations

  2001cited by this paper
• Why Older Community‐Dwelling Adults Do Not Discuss Urinary Incontinence with Their Primary Care Physicians

  2001cited by this paper
• Advancement of opioid analgesia with controlled‐release oxycodone

  2001cited by this paper
• Analysis of Incomplete Multivariate Data

  2000cited by this paper
• Why are trials in palliative care so difficult?

  2000cited by this paper
• Morphine or oxycodone in cancer pain?

  2000cited by this paper
• The significance of the American Urological Association symptom index score in the evaluation of women with bladder outlet obstruction.

  2000cited by this paper
• Defining the clinically important difference in pain outcome measures

  2000cited by this paper
• Factors hindering patients' use of medications for cancer pain.

  1999cited by this paper
• Functioning and utility for current health of patients with depression or chronic medical conditions in managed, primary care practices.

  1999cited by this paper
• Detecting selection bias in randomized clinical trials.

  1999cited by this paper
• A Revised CES-D Measure of Depressive Symptoms and a DSM-Based Measure of Major Depressive Episodes in the Elderly

  1999cited by this paper
• Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.

  1998cited by this paper
• Controlled‐release oxycodone compared with controlled‐release morphine in the treatment of cancer pain: A randomized, double‐blind, parallel‐group study

  1998cited by this paper
• Opioid tolerance: the clinical perspective.

  1998cited by this paper
• Comparative clinical efficacy and safety of a novel controlled‐release oxycodone formulation and controlled‐release hydromorphone in the treatment of cancer pain

  1997cited by this paper
• Controlled‐release oxycodone and morphine in cancer related pain

  1997cited by this paper
• Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group.

  1996cited by this paper
• A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

  1996cited by this paper
• Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials.

  1995cited by this paper
• The WHO analgesic ladder for cancer pain management. Stepping up the quality of its evaluation.

  1995cited by this paper
• Health care sought and received by men with urinary symptoms, and their views on prostatectomy.

  1995cited by this paper
• Dose-ranging study of oxycodone for chronic pain in advanced cancer.

  1993cited by this paper
• Marginal modeling of binary cross-over data.

  1993cited by this paper
• Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age.

  1993cited by this paper
• Validation of a new quality of life questionnaire for benign prostatic hyperplasia.

  1992cited by this paper
• Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays.

  1990cited by this paper
• Morphine and oxycodone hydrochloride in the management of cancer pain

  1990cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Analgesic studies of codeine and oxycodone in patients with cancer. II. Comparisons of intramuscular oxycodone with intramuscular morphine and codeine.

  1978cited by this paper

• Treatment of Opioid Withdrawal Syndrome Triggered by Oxycodone/Naloxone with Dexmedetomidine

  2023cites this paper
• Effectiveness of Opioid Switching in Advanced Cancer Pain: A Prospective Observational Cohort Study

  2023cites this paper
• Oxycodone for cancer-related pain.

  2022cites this paper
• Oxycodone for cancer-related pain.

  2022cites this paper
• Symptoms During Outpatient Cancer Treatment and Options for Their Management.

  2021cites this paper
• Aktualisierte S3-Leitlinie „Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung“

  2020cites this paper
• Comparative Efficacy of Therapeutics for Chronic Cancer Pain: A Bayesian Network Meta-Analysis

  2019cites this paper
• Effectiveness of rapid titration with intravenous administration of oxycodone injection in advanced cancer patients with severe pain.

  2019cites this paper
• Opioid-induced bowel dysfunction in cancer-related pain: causes, consequences, and a novel approach for its management.

  2018cites this paper
• Guía de práctica clínica sobre cuidados paliativos

  2018cites this paper
• Efficacy, tolerability and acceptability of oxycodone for cancer-related pain in adults: an updated Cochrane systematic review

  2018cites this paper
• Comparison of analgesic effect of oxycodone and morphine on patients with moderate and advanced cancer pain: a meta-analysis

  2018cites this paper
• Efficacy and Safety of High-Dose Controlled-Release Oxycodone in the Treatment of Moderate to Severe Pain in Patients with Advanced Cancer: A Retrospective Study

  2018cites this paper
• Oxycodone for cancer-related pain.

  2017cites this paper
• Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2017cites this paper
• Opioid-Induced Constipation Relief From Fixed-Ratio Combination Prolonged-Release Oxycodone/Naloxone Compared With Oxycodone and Morphine for Chronic Nonmalignant Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  2017cites this paper
• Are Physicians Safely Prescribing Opioids for Chronic Noncancer Pain? A Systematic Review of Current Evidence

  2016cites this paper
• The relationship between methylation and genes associated with opioid response in humans

  2016cites this paper
• Outcomes of Treatment with Opioids - the role of clinical, pharmacokinetic and genetic factors

  2016cites this paper
• Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial.

  2016cites this paper
• Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.

  2016cites this paper
• Maximizing value in opioid utilization: Is oxycodone immediate release a good option for pain management?

  2015cites this paper
• Use of Oxycodone in Management of Advanced Cancer Pain

  2015cites this paper
• Single-shot epidural-spinal anesthesia followed by oral oxycodone/naloxone and ketoprofen combination in patients undergoing total hip replacement: analgesic efficacy and tolerability.

  2015cites this paper
• Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.

  2015cites this paper
• Revue systématique et méta-analyse en médecine palliative

  2015cites this paper
• Palliative Care in Urological Cancer

  2015cites this paper
• A Systematic Review of Prospective Studies Reporting Adverse Events of Commonly Used Opioids for Cancer-Related Pain: A Call for the Use of Standardized Outcome Measures.

  2015cites this paper
• Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects of methylnaltrexone

  2014cites this paper
• Opioid switch from low dose of oral oxycodone to transdermal fentanyl matrix patch for patients with stable thoracic malignancy-related pain

  2014cites this paper
• Patients with chronic pain and dysphagia (CPD): unmet medical needs and pharmacologic treatment options

  2014cites this paper
• Efficacy and Gastrointestinal Tolerability of Oral Oxycodone/Naloxone Combination for Chronic Pain in Outpatients With Cancer

  2014cites this paper
• Clinical guideline for pharmacological management of cancer pain: the Japanese Society of Palliative Medicine recommendations.

  2013cites this paper
• Noninterventional observational study using high-dose controlled-release oxycodone (CR oxycodone) for cancer pain management in outpatient clinics.

  2013cites this paper
• Chapter 2 – How Should Opioids Be Started and Titrated in Hospital or Inpatient Settings?

  2013cites this paper
• Cancer pain therapy with a fixed combination of prolonged-release oxycodone/naloxone: results from a non-interventional study

  2013cites this paper
• Opioid withdrawal syndrome after treatment with low-dose extended-release oxycodone and naloxone in a gastric cancer patient with portal vein thrombosis.

  2013cites this paper
• Pain and Multiple Myeloma

  2013cites this paper
• Symptom management in patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cites this paper
• Chapter 1 – How Should Opioids Be Started and Titrated in Routine Outpatient Settings?

  2013cites this paper
• Cancer Pain Management: What’s New?

  2013cites this paper
• Are we using oxycodone appropriately? A utilisation review in a UK tertiary care centre

  2012cites this paper
• Abstract. In order to evaluate the efficacy and tolerability of oxycodone in moderate-severe cancer-related pain, we conducted a systematic review of randomized controlled trials (RCTs). Publications addressing the efficacy and tolerability of oxycodone in moderate-severe cancer-related pain

  2012cites this paper
• A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain

  2012cites this paper
• A systematic review of randomized trials on the effectiveness of opioids for cancer pain.

  2012cites this paper
• Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.

  2012cites this paper
• Efficacy and tolerability of oxycodone in moderate-severe cancer-related pain: A meta-analysis of randomized controlled trials.

  2012cites this paper
• Effect of Cytochrome P450 2D6 and 3A Enzyme Inhibition on the Metabolism of Oxycodone

  2011cites this paper
• Guidelines for supportive care in multiple myeloma 2011

  2011cites this paper
• High doses of oxycodone–naloxone combination may provide poor analgesia

  2011cites this paper
• Oxycodone and a Useful Book

  2011cites this paper
• Therapeutische Möglichkeiten – konservative Verfahren

  2011cites this paper
• Opioids: a two-faced Janus

  2011cites this paper
• A systematic review of oxycodone in the management of cancer pain

  2011influential citation
• The Use of High Doses of Oxycodone in an Acute Palliative Care Unit

  2011cites this paper
• Switching from oxycodone to methadone in advanced cancer patients

  2011cites this paper
• [Solutions for the clinical problems of analgesics for cancer pain treatment in Japan].

  2011cites this paper
• Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults

  2011cites this paper
• Buprenorphine for cancer pain

  2011cites this paper
• Pharmacokinetic, pharmacodynamic and pharmacogenetic aspects of oxycodone treatment in cancer pain

  2011cites this paper
• Treatment of Neuropathic Pain: The Role of Unique Opioid Agents Agents that work against central nervous system receptors may be the key to successful pain management in patients with nerve damage or injury.

  2011cites this paper
• Role of oxycodone and oxycodone/naloxone in cancer pain management

  2010cites this paper
• Morphine Versus Oxycodone in Pancreatic Cancer Pain: A Randomized Controlled Study

  2010cites this paper
• Repeated administration of oxycodone modifies the gene expression of several drug metabolising enzymes in the hepatic tissue of male Sprague‐Dawley rats, including glutathione S‐transferase A‐5 (rGSTA5) and CYP3A2

  2010influential citation
• Use of oxycodone controlled-release immediately after NSAIDs: a new approach to obtain good pain control.

  2010cites this paper
• [Morphine or oxycodone tablets for pain?].

  2010cites this paper
• Cancer Pain: Analgesics and Co‐Analgesics

  2010cites this paper
• [Efficacy of acupuncture in treatment of cancer pain: a systematic review].

  2010cites this paper
• Pharmacological approach to chronic visceral pain. Focus on oxycodone controlled release: an open multicentric study.

  2010cites this paper
• Opioidinduzierte Obstipation. Aktuelle Therapiemöglichkeiten in der palliativen Schmerztherapie

  2009cites this paper
• Langzeitanwendung von Opioiden bei nicht tumorbedingten Schmerzen (LONTS)

  2009cites this paper
• Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.

  2009influential citation
• Symptom Management in Children with Cancer

  2009cites this paper
• Pain therapy.

  2009cites this paper
• Pharmacology of opioid analgesia: Clinical principles

  2009cites this paper
• Present Status and Recent Advance of Pharmacotherapy in Cancer Pain Management

  2008cites this paper
• Opioids in people with cancer-related pain.

  2008influential citation
• Oxycodone and the Challenge of Neuropathic Cancer Pain: A Review

  2008cites this paper
• Is there a problem with oxycodone?

  2008cites this paper
• Medikamente zur post- operativen Schmerzthera- pie: Bewährtes und Neues

  2008cites this paper
• Tratamiento del dolor oncológico terminal intenso

  2008cites this paper
• Putting evidence into practice: Palliative care

  2008cites this paper
• Antalgiques et soins palliatifs

  2008cites this paper
• Oxycodone Controlled-Release as First-Choice Therapy for Moderate-to-Severe Cancer Pain in Italian Patients

  2008cites this paper
• Medikamente zur postoperativen Schmerztherapie: Bewährtes und Neues

  2008cites this paper
• Oxycodone: a review of its use in the management of pain

  2008cites this paper
• Medikamente zur postoperativen Schmerztherapie: Bewährtes und Neues

  2008cites this paper
• [Diagnosis and therapy of tumor related pain].

  2007cites this paper
• Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers

  2007influential citation
• Opioids for persistent noncancer pain.

  2007cites this paper
• Opioids for persistent noncancer pain.

  2007cites this paper
• Barriers to pain management in the rehabilitation of the surgical oncology patient

  2007cites this paper
• Palliative Care Pharmacotherapy Literature Summaries and Analyses

  2007cites this paper
• Cancer pain management modalities and positioning of oxycodone

  2007cites this paper
• Efficacy of pharmacist-palliative care physician cooperative screening activity

  2007cites this paper
• What's new in …Palliative care

  2007cites this paper
• Hydromorphone in the management of cancer-related pain: an update on routes of administration and dosage forms.

  2007cites this paper
• Endogenous opiates and behavior: 2006.

  2007cites this paper
• Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy

  2006cites this paper
• PC-FACS

  2006cites this paper